Back to Results
First PageMeta Content
Stem cells / Medical emergencies / Cell biology / Cell therapy / Angiology / Biomarker / Myocardial infarction / Ischemia / Pre-clinical development / Biology / Medicine / Biotechnology


Food and Drug Administration Center for Biologics Evaluation and Research BIOLOGICAL RESPONSE MODIFIERS ADVISORY COMMITTEE Meeting #37, March 18-19, 2004
Add to Reading List

Document Date: 2004-03-16 07:29:51


Open Document

File Size: 61,50 KB

Share Result on Facebook

Facility

Hilton Hotel / /

IndustryTerm

cardiac cellular therapy products / heterogeneous cellular product / treatment of cardiac disease / myoblast products / cellular product / stem cell products / stainless steel / cellular products / treatment of cardiac diseases / human cellular product / administered cellular products / analogous product / human cellular products / delivery devices / concentrated product / /

MedicalCondition

Scar / cardiac injury / embolism / acute ischemic heart disease / disease / ischemic disease / cardiac disease / Left ventricular dysfunction / ischemic heart disease / cardiac diseases / clinical disease / /

MedicalTreatment

invasive procedures / balloon catheter / placebos / catheter / catheters / /

Organization

Food and Drug Administration Center for Biologics Evaluation / Research BIOLOGICAL RESPONSE MODIFIERS ADVISORY COMMITTEE / /

Product

Endovascular injection / /

SocialTag